Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 96,300 shares, a growth of 20.7% from the May 31st total of 79,800 shares. Based on an average trading volume of 1,130,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.6% of the shares of the company are short sold.
Qualigen Therapeutics Stock Down 3.6 %
Shares of Qualigen Therapeutics stock opened at $0.17 on Tuesday. The firm’s fifty day simple moving average is $0.25 and its 200-day simple moving average is $0.39. Qualigen Therapeutics has a 12 month low of $0.14 and a 12 month high of $1.26.
Qualigen Therapeutics Company Profile
See Also
- Five stocks we like better than Qualigen Therapeutics
- 3 REITs to Buy and Hold for the Long Term
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What does consumer price index measure?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- The How And Why of Investing in Oil Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.